Skip to main content
Log in

Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Cellular phosphotyrosine levels are regulated by the balance between protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). It is supposed that this balance is disturbed in tumour cells, making the increased or altered activity of PTKs and PTPs likely hallmarks of tumour tissues. Indeed it could be shown that the PTK activity was increased in breast cancer in correlation with prognosis (Hennipmanet al., Cancer Res. 49, 516–522, 1989). In the present report we measured the PTP activities in breast cancer and normal breast tissues. An increase of approximately three- to four-fold was measured in the cytosolic tumour fractions compared to normal, whereas the solubilized membrane fraction PTP activity showed an increase in tumours of approximately 1.5-fold. Remarkably, the membrane PTP activity correlated with the presence of tumour positive axillary lymph nodes (p = 0.004), whereas the cytosolic PTP activity correlated with the mitotic index, a higher PTP activity occurring when the mitotic index was higher than 10 (p = 0.0004). These results indicate that membrane PTP activity may be considered as an index of metastatic potential, whereas cytosolic PTP activity may be a measure of the growth capacity of the tumour. The increase of PTP activity in breast cancers was confirmed by enzyme-histochemical studies. In frozen sections of tumours a strong to moderate activity was found in both tumour cells and interstitial cells. In the interstitium membrane activity was most pronounced, whereas in the tumour cells diffuse staining of the cytoplasm together with a clear membrane staining was demonstrated. Immunoblotting with anti-phosphotyrosine antibodies also reveals differences between the tumours and normal tissues, confirming the disturbance of the balance between protein tyrosyl phosphorylation and dephosphorylation in the tumour cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kmiecik TE, Shalloway D: Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49: 65–73, 1987

    Google Scholar 

  2. Piwnica-Worms H, Saunders KB, Roberts TM, Smith AE, Cheng SH: Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49: 75–82, 1987

    Google Scholar 

  3. Cartwright CA, Eckhart W, Simon S, Kaplan PL: Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 49: 83–91, 1987

    Google Scholar 

  4. Veillette A, Bookman MA, Horak EM, Samelson LE, Bolen JB: Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosineprotein kinase p561ck. Nature 338: 257–259, 1989

    Google Scholar 

  5. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212, 1990

    Google Scholar 

  6. Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron 9: 383–391, 1992

    Google Scholar 

  7. Streuli M, Krueger NX, Tsai AYM, Saito H: A family of receptor-linked protein tyrosine phosphatases in humans and Drosophila. Proc Natl Acad Sci USA 86: 8698–8702, 1989

    Google Scholar 

  8. Charbonneau H, Tonks NK, Kumar S, Diltz CD, Harrylock M, Cool DE, Krebs EG, Fischer EH, Walsh KA: Human placenta protein-tyrosine-phosphatase: Amino acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci USA 86: 5252–5256, 1989

    Google Scholar 

  9. Tonks NK, Diltz CD, Fischer EH: Characterization of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263: 6731–6737, 1988

    Google Scholar 

  10. Tonks NK, Diltz CD, Fischer EH: Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263: 6722–6730, 1988

    Google Scholar 

  11. Streuli M, Krueger NX, Thai T, Tang M, Saito H: Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J 9: 2399–2407, 1990

    Google Scholar 

  12. Fischer EH, Charbonneau H, Tonks NK: Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes. Science 253: 401–406, 1991

    Google Scholar 

  13. Brautigan DL: Great expectations: protein tyrosine phosphatases in cell regulation. Biochim Biophys Acta 1114: 63–77, 1992

    Google Scholar 

  14. Guan K, Dixon JE: Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249: 553–556, 1990

    Google Scholar 

  15. Guan K, Broyles SS, Dixon JE: A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 350: 359–362, 1991

    Google Scholar 

  16. Sap J, D'Eustachio P, Givol D, Schlessinger J: Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc Natl Acad Sci USA 87: 6112–6116, 1990

    Google Scholar 

  17. Charbonneau H, Tonks NK, Walsh KA, Fischer EH: The leukocyte common antigen (CD45): A putative receptorlinked protein tyrosine phosphatase. Proc Natl Acad Sci USA 85: 7182–7186, 1988

    Google Scholar 

  18. Cool DE, Tonks NK, Charbonneau H, Walsh KA, Fischer EH, Krebs EG: cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. Proc Natl Acad Sci USA 86: 5257–5261, 1989

    Google Scholar 

  19. Plutzky J, Neel BG, Rosenberg RD: Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 89: 1123–1127, 1992

    Google Scholar 

  20. Shen S-H, Bastien L, Posner BI, Chrétien P: A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 352: 736–739, 1991

    Google Scholar 

  21. Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GEJ: Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Canc Res 49: 516–521, 1989

    Google Scholar 

  22. Ottenhoff-Kalff AE, Rijksen G, van Beurden EACM, Hennipman A, Michels AA, Staal GEJ: Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product. Cancer Res 52: 4773–4778, 1992

    Google Scholar 

  23. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976

    Google Scholar 

  24. Hubbard AL, Wall DA, Ma A: Isolation of rat hepatocyte plasma membranes. I. Presence of the three major domains. J Cell Biol 96: 217–229, 1983

    Google Scholar 

  25. Beutler E: In: Red Cell Metabolism: A Manual of Biochemical Methods. Grune & Stratton, New York, 1975, pp 38–70

    Google Scholar 

  26. Rijksen G, van Oirschot BA, Staal GEJ: Nonradioactive assays of protein-tyrosine kinase activity using anti-phosphotyrosine antibodies. In: Hunter T, Sefton BM (eds) Methods in Enzymology, Volume 200, Protein Phosphorylation. Academic Press Inc., San Diego, California, 1991, pp 98–107

    Google Scholar 

  27. Kidd KR, Kerns B-JM, Dodge RK, Wiener JR: Histochemical staining of protein-tyrosine phosphatase activity in primary human mammary carcinoma: Relationship with established prognostic indicators. J Histochem Cytochem 40: 729–735, 1992

    Google Scholar 

  28. Hunter T, Sefton BM: Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci USA 77: 1311–1315, 1980

    Google Scholar 

  29. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182, 1987

    Google Scholar 

  30. Ingebritsen TS: Phosphotyrosyl-protein phosphatases II. Identification and characterization of two heat-stable protein inhibitors. J Biol Chem 264: 7754–7759, 1989

    Google Scholar 

  31. Brautigan DL, Bornstein P, Gallis B: Phosphotyrosyl-protein phosphatase specific inhibition by Zn2 +. J Biol Chem 256: 6519–6522, 1981

    Google Scholar 

  32. Marx J: Cellular changes on the route to metastasis. Science 259: 626–629, 1993

    Google Scholar 

  33. Partenen S, Pekonen F: Histochemically demonstrable phosphotyrosyl-protein phosphatase in normal human breast, in benign breast diseases, and in breast cancer. Anticancer Research 9: 667-1989

    Google Scholar 

  34. Klarlund JK: Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell 41: 707–717, 1985

    Google Scholar 

  35. Rijksen G, Völler MCW, Van Zoelen EJJ: Orthovanadate both mimics and antagonizes the transforming growth factor β action on normal rat kidney cells. J Cell Phys 154: 393–401, 1993

    Google Scholar 

  36. Zhai Y-F, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW: Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53: 2272–2278, 1993

    Google Scholar 

  37. Zheng XM, Wang Y, Pallen CJ: Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature 359: 336–339, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ottenhoff-Kalff, A.E., van Oirschot, B.A., Hennipman, A. et al. Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer. Breast Cancer Res Tr 33, 245–256 (1995). https://doi.org/10.1007/BF00665949

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00665949

Key words

Navigation